Murray H. Passo

The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic arthritis

Jack Bleesing, Anne E. Prada, David Siegel et al. · Arthritis & Rheumatism · 2007 · 322 citations

Veterinary Medicine, Immunology, Pathobiology +15

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

Alexei A. Grom, Joyce Villanueva, Susan Lee et al. · The Journal of Pediatrics · 2003 · 281 citations

Life Sciences, Immunology, Pathology +16

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

Joyce Villanueva, Susan Lee, Edward H. Giannini et al. · Arthritis Research & Therapy · 2004 · 243 citations · Full text

Life Sciences, Immunology, Pathology +15

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The childhood myositis assessment scale (CMAS): a quantitative tool for the evaluation of muscle function

Daniel J. Lovell, Carol B. Lindsley, Robert M. Rennebohm et al. · Arthritis & Rheumatism · 1999 · 242 citations

Medicine, Pediatrics, Physical Medicine +15

Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies

Adam M. Huber, Brian M. Feldman, Robert M. Rennebohm et al. · Arthritis & Rheumatism · 2004 · 235 citations

Medicine, Child Health, Pediatrics +14